Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025)

Elanco Animal Health has disclosed Accumulated Expenses across 9 years of filings, most recently posting $206.0 million for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $206.0 million, up 16.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $206.0 million (up 16.38% YoY), and the FY2025 annual result was $206.0 million, up 16.38% from the prior year.
• Accumulated Expenses came in at $206.0 million for Q4 2025 at Elanco Animal Health, up from $177.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $206.0 million in Q4 2025 to a low of $110.0 million in Q1 2023.
• The 5-year median for Accumulated Expenses is $141.0 million (2022), against an average of $144.8 million.
• Across the five-year window, Accumulated Expenses jumped 116.78% in 2021 and decreased 21.08% in 2022, its largest moves.
• Elanco Animal Health's Accumulated Expenses stood at $185.0 million in 2021, then retreated by 21.08% to $146.0 million in 2022, then advanced by 7.53% to $157.0 million in 2023, then climbed by 12.74% to $177.0 million in 2024, then climbed by 16.38% to $206.0 million in 2025.
• The last three Accumulated Expenses figures came in at $206.0 million (Q4 2025), $177.0 million (Q4 2024), and $157.0 million (Q4 2023), per Business Quant data.